CAH vs TOI
CAH: Cardinal Health is a major healthcare services provider connecting manufacturers and healthcare providers through its extensive pharmaceutical and medical supply chain distribution network. TOI: A leading value-based community oncology platform that manages cancer care populations through capitated and fee-for-service contracts to reduce costs and improve patient outcomes.
Side-by-side fundamentals
| Metric | CAH | TOI | Edge |
|---|---|---|---|
| Price | $238.96 | $6.22 | |
| Market cap | $55.6B | $633M | |
| P/E as of 2026-10-08 | 36.52 | n/a | |
| Net margin | +0.7% | -12.1% | CAH higher |
| Gross margin FY2026, SEC XBRL | +3.8% | n/a | |
| Operating margin | +1.0% | -7.2% | CAH higher |
| ROA | +3.0% | -36.8% | CAH higher |
| Debt / equity as of 2026-09-03 | 5.65 | 14.58 | CAH lower |
| Revenue growth (YoY) as of 2026-09-03 | +12.9% | +35.4% | TOI higher |
| Revenue CAGR (3y) SEC XBRL | +7.4% | +25.8% | TOI higher |
| Dividend yield as of 2026-09-03 | +0.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 19 | 0 | CAH higher |
| Beta as of 2026-09-03 | 0.27 | 1.58 | |
| 1-year return | +51.5% | +78.6% | TOI higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.